- Who We Are
- What We Do
- News and Events
- Contact Us
Understanding the scope of how Alzheimer’s disease affects people is difficult. Overall, its prevalence is increasing and there is a huge unmet need for successful trials and new therapies. With the highest trial failure rate of any therapeutic area at 99.6%, this eBook discusses the challenges and how the emergence of new approaches and investments in technology and research are paving a path forward.
[pardot-form id=”3032″ title=”eBook Form”]